Max Biopharma Inc is categorized under Noncommercial Research Organizations in Los Angeles, CA and active since 2010.
Max Biopharma Inc was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Farhad Parhami at the company’s single location by writing to 612 South Barrington Avenue, Los Angeles, California CA 90049 or by phoning (310) 283-2596. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Max Biopharma Inc |
Contact Person: | Farhad Parhami |
Address: | 612 South Barrington Avenue, Los Angeles, California 90049 |
Phone Number: | (310) 283-2596 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Research Organizations |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Max Biopharma Inc was started in 2010 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Farhad Parhami for inquiries that concern Max Biopharma Inc by calling the company number (310) 283-2596, as your correspondence is most welcome. Additionally, the physical location of the single location of Max Biopharma Inc can be found at the coordinates 34.057614,-118.467917 as well as the street address 612 South Barrington Avenue in Los Angeles, California 90049.
For its online presence, you may visit Max Biopharma Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.